Pharmacovigilance Market Dynamics and Service Provider Benchmarking (2nd edition)

Description

Staying current on market dynamics and trends in the pharma world is a tall order. ISR surveyed 100 decision-makers in the pharmacovigilance space to gather their insights regarding the market and where it’s heading. Survey respondents shared their experience regarding how their companies’ pharmacovigilance activities are split between processes, how much of their work is outsourced and to what types of providers, and both in-house and outsourced personnel locations.
When ISR gathers data on selection and performance, two audiences are typically in mind. The first audience is sponsor companies. We want to help decision-makers at sponsor organizations understand how peers in the industry select providers and how providers have performed for recent customers. The second audience is providers. We strive to assist providers in understanding how they are viewed through the eyes of their customers so they can better promote their strengths and improve areas where they may be falling short.

Preview-cover-2019-Pharmacovigilance-Market-Dynamics-and-Service-Provider-Benchmarking-(2nd-edition)

Study Sponsors

  • Insights on the current pharmacovigilance market and what it is expected to look like in the next three years
  • Trends in technology use for pharmacovigilance activities, including approaches to social media and ways to make pharmacovigilance work less manual
  • How decision-makers in the industry select providers and how providers have performed for recent customers

CROs, Pharmacovigilance Providers, and Software Providers

  • Which pharmacovigilance/ drug safety activities are most prevalent, and which are most commonly outsourced
  • The most critical capabilities customers are searching for when selecting a pharmacovigilance provider
  • Which providers top the lists for perceived leadership, familiarity, proposal volume, and reported use of their pharmacovigilance services
  • How your company’s performance is rated along a variety of attributes and how competitors perform along the same dimensions
  • Pharmacovigilance Market and Outsourcing Dynamics
  • Provider Selection
  • Provider Perceptions and Interactions
  • Provider and Software Performance
  • Trends in Pharmacovigilance
  • Study Data

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Pharmacovigilance Market and Outsourcing Dynamics

Primary Section Takeaways
Pharmacovigilance Activities by Process
Pharmacovigilance Activities by Life Cycle Stage
Proportion of Pharmacovigilance Activities Outsourced
Case Processing Spend by Organization Type
Regulatory Reporting Spend by Organization Type
Benefit-Risk Management Spend by Organization Type
Outsourcing Frequency by Service
Location of In-house Pharmacovigilance Employees
Location of Outsourced Pharmacovigilance Personnel

Provider Selection

Primary Section Takeaways
Preferred Providers

Frequency of Use
Number of Preferred Providers

Use of a Single Pharmacovigilance Provider
Most Important Capabilities for Pharmacovigilance Provider

Provider Perceptions and Interactions

Primary Section Takeaways
Pharmacovigilance Provider Leaders, Unprompted
Pharmacovigilance Provider Leaders, Prompted
Pharmacovigilance Provider Familiarity
Pharmacovigilance Providers to Include in RFP Process
Pharmacovigilance Provider Usage
Summary Table

Provider and Software Performance

Primary Section Takeaways
A Note on Harvey Ball Calculations
Performance Across Service Providers
Provider Performance: Capabilities
Provider Performance: Management/Delivery
Performance Across Softwares
Software Performance: Capabilities
Software Performance: Quality/Usability

Trends in Pharmacovigilance

Primary Section Takeaways
Database Structure Used
Adverse Event Sources
How to Make Pharmacovigilance Work Less Manual
Adoption of Artificial Intelligence in Pharmacovigilance Technologies
Social Media

Use of Social Media to Search for Patient Health Concerns
Use of Social Media to Capture Adverse Events

Effect on Pharmacovigilance Activities and Budget

Study Data

Pharmacovigilance Activities by Process
Proportion of Pharmacovigilance Activities Outsourced
Pharmacovigilance Activities by Life Cycle Stage
Location of In-house Pharmacovigilance Employees
Location of Outsourced Pharmacovigilance Personnel
Use of Preferred Providers
Number of Preferred Providers

Currently
In 3 Years

Case Processing Spend by Organization Type
Regulatory Reporting Spend by Organization Type
Benefit-Risk Management Spend by Organization Type
Use of a Single Pharmacovigilance Provider
Outsourcing Frequency by Service
Most Important Capabilities for Pharmacovigilance Provider
Pharmacovigilance Provider Leaders, Unprompted
Other Responses
Pharmacovigilance Provider Leaders, Prompted
Pharmacovigilance Provider Familiarity
Pharmacovigilance Providers to Include in RFP Process
Pharmacovigilance Provider Usage
Pharmacovigilance Provider Performance Drill-downs

Accenture
Activa CRO
Apcer Life Sciences
Ashfield Healthcare, formerly Drug Safety Alliance
Bioclinica
Chiltern, a Covance company
Cognizant
Covance
Drug Safety Navigator
ICON
IQVIA, formerly Quintiles
Kinapse, a Syneos Health Company
Medpace
MMS Holdings
Navitas Life Sciences
NDA Group
Oviya Medsafe
Parexel
PharmaLex
PharSafer
PPD
PRA/RPS
Premier Research
PrimeVigilance
ProPharma Group
PROSAR Pharmacovigilance
Quanticate
RxLogix
Sciformix, a Covance company
SGS
SJ Pharma Consulting
Symogen
Syneos Health, formerly INC Research and inVentiv Health
Tata
UBC
ZEINCRO

Use of Safety Databases and Data Capture Tools
Database Performance Drill-downs

AB-Cube
AgilePV
Appian
Aris Global ARISg (data capture)
EudraVigilance Database Management System
EXTEDO
FAERS (FDA Adverse Event Reporting System)
Genpact, including CommonWealth Informatics
Individual Case Safety Reports / ICSR Databases
In-house developed database
My Meds and me
Online Business Applications, Inc., IRMS-AE – Adverse Event Software
Oracle Argus Safety (database) / Oracle Empirica (data capture)
PharmacoSoftware vigiS3
RxLogix
SAS
Sparta Systems, TrackWise
VigiBase

Database Structure Used
Adverse Event Sources
How to Make Pharmacovigilance Work Less Manual
Adoption of Artificial Intelligence in Pharmacovigilance Technologies
Use of Social Media to Search for Patient Health Concerns
Use of Social Media to Capture Adverse Events
Social Media’s Effect on Pharmacovigilance Activities and Budget

Demographics

Company Type
Company Size
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Visibility into Safety Activities
Pharmacovigilance / Drug Safety Responsibilities
Type of Pharmacovigilance / Drug Safety Responsibilities
Pharmacovigilance / Drug Safety Responsibilities by Phase

Additional information

License

, ,